TipRanks
Go Ultimate55% OFF

AIM ImmunoTech (0A4Y) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0A4Y Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to AIM ImmunoTech in the past 3 months

0A4Y Stock 12 Month Forecast

$4.25â–˛(2607.01% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for AIM ImmunoTech in the last 3 months. The average price target is $4.25 with a high forecast of $7.00 and a low forecast of $1.50. The average price target represents a 2607.01% change from the last price of $0.16.
Highest Price Target$7.00Average Price Target$4.25Lowest Price Target$1.50

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0A4Y
Price TargetFollowArticle
Ascendiant$9→$7buy4358.60%UpsideReiterated08/19/26
Maxim Group$1.50buy855.41%UpsideReiterated08/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AIM ImmunoTech

3 Months
Edward Woo
Edward WooAscendiant
Success Rate3/11 ratings generated profit
27%
Average Return
-7.30%

Copying Edward Woo's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of -7.30% per trade.

1 Year
Edward Woo
Edward WooAscendiant
Success Rate1/11 ratings generated profit
9%
Average Return
-62.20%

Copying Edward Woo's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -62.20% per trade.

2 Years
Edward Woo
Edward WooAscendiant
Success Rate0/11 ratings generated profit
0%
Average Return
-78.77%

Copying Edward Woo's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -78.77% per trade.

0A4Y Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 0A4Y
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy54322
Buy00000
Hold00000
Sell00000
Strong Sell00000
total54322

In the current month, 0A4Y has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0A4Y average Analyst price target in the past 3 months is 4.25.

0A4Y Financial Forecast

$-5$-3.75$-2.5$-1.25$0Q3 2025Q2 2026Q2 2027
Consensus$-0.43

0A4Y Earnings Forecast

Next quarter’s earnings estimate for 0A4Y is -$0.43 with a range of ― to ―. The previous quarter’s EPS was -$0.43. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$21,999$22,999.5$24,000$25,000.5$26,001Q3 2025Q2 2026Q2 2027
Consensus$26K

0A4Y Sales Forecast

Next quarter’s sales forecast for 0A4Y is $26.00K with a range of ― to ―. The previous quarter’s sales results were $26.00K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0A4Y Stock Forecast FAQ

What is GB:0A4Y’s average 12-month price target, according to analysts?
Based on analyst ratings, AIM ImmunoTech’s 12-month average price target is $4.25.
What is GB:0A4Y’s upside potential, based on the analysts’ average price target?
AIM ImmunoTech has 2607.01% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AIM ImmunoTech a Buy, Sell or Hold?
AIM ImmunoTech has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is AIM ImmunoTech’s share price target?
The average share price target for AIM ImmunoTech is $4.25. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $7.00, and the lowest forecast is $1.50. The average share price target represents a 2607.01% increase from the current price of $0.157.
What do analysts say about AIM ImmunoTech?
AIM ImmunoTech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of AIM ImmunoTech?
To buy shares of GB:0A4Y, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.